Peter MacCallum Cancer Centre,
Melbourne, Australia

Dr James Buteau completed his nuclear medicine specialisation in Canada, then joined Peter Mac in 2019 as a clinical and research fellow. He just completed the second year of his PhD, which investigates the role of PSMA PET/CT for prostate cancer diagnosis in the PRIMARY2 trial, and Terbium-161-PSMA therapy for men with mCRPC in the VIOLET trial.